This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignee: Georgetown University. Active years: 2018-2021.
Company Filing History:
Years Active: 2018-2021
Title: Shujie Hou: Innovator in Androgen Receptor Inhibitors
Introduction
Shujie Hou is a prominent inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of medicinal chemistry, particularly in the development of androgen receptor inhibitors. With a total of 5 patents, her work focuses on innovative methods for treating prostate cancer.
Latest Patents
One of her latest patents is titled "Small molecule androgen receptor inhibitors and methods of use thereof." This patent provides small molecule carbazole compounds that serve as androgen receptor inhibitors. The methods outlined in this patent include the use of these compounds in treating prostate cancer, including castration-resistant prostate cancer and enzalutamide-resistant prostate cancer. Another notable patent is "Synthesis of mahanine and related compounds," which discloses methods for synthesizing mahanine and related compounds through various chemical reactions.
Career Highlights
Shujie Hou is affiliated with Georgetown University, where she conducts her research and development work. Her innovative approaches have garnered attention in the scientific community, contributing to advancements in cancer treatment.
Collaborations
She has collaborated with notable colleagues, including Milton L Brown and Partha Banerjee, enhancing the impact of her research through teamwork and shared expertise.
Conclusion
Shujie Hou's contributions to the field of medicinal chemistry, particularly in the development of androgen receptor inhibitors, highlight her role as an influential inventor. Her work continues to pave the way for new treatments in prostate cancer, showcasing the importance of innovation in healthcare.